Scarica l'app Stockscreener
28.08
19.47%
4.48
Precedente Chiudi:
$23.60
Aprire:
$27.5
Volume 24 ore:
72,971
Relative Volume:
1.52
Capitalizzazione di mercato:
$1.35B
Reddito:
$27,600
Utile/perdita netta:
$-36.04M
Rapporto P/E:
-35.24
EPS:
-0.7968
Flusso di cassa netto:
$-1.66M
1 W Prestazione:
+23.77%
1M Prestazione:
+190.71%
6M Prestazione:
+746.19%
1 anno Prestazione:
+469.60%
Intervallo 1D:
$27.37
$28.39
Intervallo di 1 settimana:
$20.15
$30.23
Portata 52W:
$2.76
$30.23
Nanobiotix Adr Stock (NBTX) Company Profile
Confronta NBTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
28.08 | 1.14B | 27,600 | -36.04M | -1.66M | -0.7968 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.57 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.52 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-28 | Iniziato | Guggenheim | Buy |
| 2023-12-08 | Iniziato | Leerink Partners | Outperform |
| 2021-01-06 | Iniziato | Evercore ISI | Outperform |
Nanobiotix Adr Borsa (NBTX) Ultime notizie
Nanobiotix (NASDAQ:NBTX) Shares Down 12%Should You Sell? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's Why - MarketBeat
Morning Market Movers: INBS, UPC, GLTO Spark Big Moves - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's Why - MarketBeat
FY2027 EPS Estimates for Nanobiotix Boosted by HC Wainwright - Defense World
Nanobiotix SA ADR Reports Revenue Surge Amid Strategic Advances - TipRanks
Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket - Benzinga
Morning Market Movers: SPRC, VALN, NBY, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Reaches New 1-Year HighHere's Why - MarketBeat
NANOBIOTIX Announces Updated Phase 1 Results Continuing to Support JNJ-1900 (NBTXR3) Plus Anti-PD-1 as a Potential New 1L or 2L+ Option in Anti-PD-1 Naïve or Resistant R/M-HNSCC - GlobeNewswire Inc.
Nanobiotix (NASDAQ:NBTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Stocks Moving Premarket: PEPG, WOK, ICU, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Hits New 52-Week HighHere's Why - MarketBeat
Nanobiotix S.A. Sponsored ADR (NASDAQ:NBTX) Short Interest Up 23.7% in August - MarketBeat
Nanobiotix (NASDAQ:NBTX) Trading 11.8% HigherTime to Buy? - MarketBeat
Biotech Stocks Moving Premarket: QLGN, MBX, HSDT, And Other Gainers & Losers - RTTNews
Nanobiotix (NASDAQ:NBTX) Shares Up 5.7%What's Next? - MarketBeat
Nanobiotix announces new results from JNJ-1900 study - TipRanks
Nanobiotix Announces Voting Rights and Share Capital Update - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.2% – Here’s Why - Defense World
Nanobiotix (NASDAQ:NBTX) Stock Price Up 2.9% – Should You Buy? - Defense World
Guggenheim Reaffirms Their Buy Rating on Nanobiotix (NBTX) - The Globe and Mail
Nanobiotix (NASDAQ:NBTX) Stock Price Down 2.5% – Should You Sell? - Defense World
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
Nanobiotix Sa ADR Reports Q1 2025 Progress - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
Guggenheim cuts Nanobiotix stock target to $8, maintains buy - Investing.com
Nanobiotix SA ADR Reports 2024 Financial Results - TipRanks
Nanobiotix Stock Gains as Dosing Begins in Mid-Stage NSCLC Study - Nasdaq
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study - TipRanks
Nanobiotix (NBTX) Stock Soared 107.9% on a Global Pharma Deal - AskTraders.com
Stock Market News and Commentary - Barchart.com
Nanobiotix S.A.Sponsored ADR (NBTX) - Zacks Investment Research
NBTX News Today | Why did Nanobiotix stock go up today? - MarketBeat
Nanobiotix (NBTX) Stock Price, News & Analysis - MarketBeat
Nanobiotix Adr Azioni (NBTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
2.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):